Summary
Thermo Fisher Scientific Inc. (TMO) has filed a Form 8-K to announce its financial results for the fiscal quarter ended September 28, 2024. The press release detailing these results, furnished as Exhibit 99.1, is the primary piece of new information for investors in this filing. This report serves as the official notification of the company's performance during the third quarter of its fiscal year.
Key Highlights
- 1Announcement of Q3 2024 financial results.
- 2Press release detailing Q3 2024 earnings furnished as Exhibit 99.1.
- 3Filing made on October 23, 2024, for results of the quarter ended September 28, 2024.
- 4Information contained in the press release is furnished, not officially filed under Section 18 of the Exchange Act.
- 5Standard 8-K filing for quarterly earnings disclosure.
Frequently Asked Questions
The main purpose of this 8-K filing is to announce Thermo Fisher Scientific Inc.'s financial results for the fiscal quarter ended September 28, 2024. The detailed press release containing these results is provided as an exhibit.
The detailed financial results for the fiscal quarter ended September 28, 2024, are available in the press release furnished as Exhibit 99.1 to this Form 8-K filing.
No, the information contained in the press release is considered 'furnished' and not 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, unless specifically incorporated by reference into a future filing.